spacer
home > epc > spring 2009 > competing with big pharma
PUBLICATIONS
European Pharmaceutical Contractor

Competing with Big Pharma

Good ideas for new drugs can come from anywhere. There was a time – now it seems like ancient history – when virtually all ideas came from the R&D departments of large pharmaceutical companies. Today, they often come from research carried out by dedicated groups of scientists at universities and small and medium-sized biotech firms, or even ‘virtual’ research groups connected by the internet.

Regardless of how it’s achieved, coming up with a concept for a new drug is not a random event. It starts with deciding what questions to ask in order to identify potential targets for a disease, and later focuses on developing strategies to find effective candidates that selectively affect those targets. Through hard work and trial and error, thousands of labs across the UK are developing new candidates every day. Thankfully, with some regularity, one scientist will turn to his or her colleagues and say, “I think we’ve got something here.” Then what?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Mark Crane joined Ricerca as Vice President, Business Development and Marketing in June 2007. Mark has overseen the development of the new Ricerca ‘IP to IND’ brand, as well as the development of the website and sales literature. Prior to joining Ricerca, Mark served as Vice President, Sales and Marketing, for both Bridge Global Pharmaceutical Services and Quest Pharmaceutical Services. Mark was also a Vice President, of Global Business Development, Preclinical/Discovery Services for MDS Pharmaceutical Services, and held various posts at MDS Panlabs, AVANTEC, Inc and the Perkin Elmer Corporation. He holds a BS degree in Health Education/Community Health from Western Connecticut State University at Danbury.

spacer
Mark Crane
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

The need for a blueprint emergency plan to avoid a HPAPI crisis

SMi reports: Taro Pharmaceuticals, Purdue Pharma and Sakari Consultants to present at HPAPI USA taking place on October 21st – 22nd in Boston
More info >>

White Papers

Accelerate Your Database Lock Using Clean Patient Optics

Bioclinica

Because a key step towards database lock is obtaining clean data for all patients, the ability to verify that data are clean early accelerates the ability to lock the clinical database. This ultimately shortens the overall study timeline while ensuring the quality of your data. However, this can be challenging when manually reviewing study data, particularly with larger studies.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement